Full Steam Ahead At Ferring To Unlock Microbiome Potential For Reproduction

Having acquired Rebiotix Inc. in 2018 to advance its research into the human microbiome, Ferring Pharmaceuticals AS has unveiled a large clinical program involving 9,000 people to investigate its role in reproductive medicine and women’s health, as well as gastroenterology.

The Swiss company and Swedish partner the Karolinska Institutet have announced a five-year extension of their collaboration signed back in January 2016, which led to the establishment of the Centre for Translational Microbiome Research (CTMR)